UroGen Pharma Ltd.

Swiss National Bank URGN

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/7/2026

Shares

77,800

Value ($000)

1,399

Weight

0.0%

2019 Q4 - 2026 Q1 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/7/2026	1,399	0.0%	77,800	3/31/2026
2024 Q4	2/10/2025	603	0.0%	56,600	12/31/2024
2024 Q3	11/7/2024	719	0.0%	56,600	9/30/2024
2022 Q1	5/9/2022	417	0.0%	47,900	3/31/2022
2021 Q4	2/8/2022	417	0.0%	43,900	12/31/2021
2021 Q3	11/8/2021	738	0.0%	43,900	9/30/2021
2021 Q2	8/6/2021	670	0.0%	43,900	6/30/2021
2021 Q1	5/7/2021	828	0.0%	42,500	3/31/2021
2020 Q4	2/5/2021	766	0.0%	42,500	12/31/2020
2020 Q3	11/9/2020	820	0.0%	42,500	9/30/2020
2020 Q2	8/5/2020	1,040	0.0%	39,800	6/30/2020
2020 Q1	5/8/2020	615	0.0%	34,500	3/31/2020
2019 Q4	2/6/2020	1,135	0.0%	34,000	12/31/2019